Showing results (2391-2400 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|February 4, 2009
A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosisRosanna Cozzolino, Gaetano Calì, Maurizio Bifulco, et al.Investigational New Drugs|October 29, 2008
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancerWilliam P Tew, Delia Radovich, Eileen O'Reilly, et al.Investigational New Drugs|September 6, 2008
Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignanciesH Sayar, Z Shen, S J Lee, et al.Investigational New Drugs|September 3, 2008
Effect of oral administration of kefir on serum proinflammatory cytokines on 5-FU induced oral mucositis in patients with colorectal cancerE Topuz, D Derin, G Can, et al.Investigational New Drugs|August 30, 2008
Rhinitis and epistaxis in patients treated by anti-angiogenic therapyV Prulière-Escabasse, E Escudier, R Balheda, et al.Investigational New Drugs|February 14, 2009
A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimenLida Mina, Ian Krop, Robin T Zon, et al.Investigational New Drugs|April 4, 2009
Proteinuria and proximal tubule lesions induced by an anti-integrin monoclonal antibody treatment: case reportAndrea Gombos, Hassan Izzedine, Benjamin Besse, et al.Investigational New Drugs|March 31, 2010
5k, a novel β-O-demethyl-epipodophyllotoxin analogue, inhibits the proliferation of cancer cells in vitro and in vivo via the induction of G2 arrest and apoptosisDanqing Xu, Ji Cao, Shijing Qian, et al.Investigational New Drugs|May 15, 2010
Cytotoxicity, apoptosis and study of the DNA-binding properties of bi- and tetranuclear gallium(III) complexes with heterocyclic thiolato ligandsBeatriz Gallego, Milena R Kaluđerović, Harish Kommera, et al.Pageof 372